Vmn2r32 activators are a class of chemicals that can modulate the function of the vomeronasal type 2 receptor 32 (Vmn2r32), a G protein-coupled receptor (GPCR) implicated in chemosensory signaling. These activators can engage with the Vmn2r32 or its associated signaling pathways, leading to an alteration in receptor activity. The class includes various molecules that can enhance intracellular second messenger concentrations, such as cyclic adenosine monophosphate (cAMP), or influence the activity of downstream kinases like protein kinase A (PKA). Activators within this class can exert their effects by either direct interaction with the receptor or through modulation of the receptor's signaling cascade. For instance, compounds that increase the intracellular levels of cAMP can activate PKA, which in turn can phosphorylate the GPCR, resulting in a change in the receptor's activity.
The signaling mechanisms utilized by Vmn2r32 activators are diverse, encompassing various biochemical pathways that facilitate GPCR signaling. Some activators work by inhibiting the enzymatic breakdown of second messengers, thereby sustaining or amplifying the receptor signal. Others act as ionophores, altering the intracellular concentration of ions such as calcium, which serves as a crucial signaling molecule in GPCR pathways. Additionally, there are activators that can influence the function of other enzymes like phospholipase C or kinases that are integral to the signaling network of GPCRs. By modulating these enzymes, Vmn2r32 activators can indirectly affect the receptor's activity. It is through such intricate interactions within the cellular signaling framework that these chemicals can modulate the function of Vmn2r32, leading to an alteration in its signaling output.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which prevents cAMP breakdown, thus enhancing GPCR signaling which could possibly activate Vmn2r32. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate GPCRs and regulate their function, which could possibly activate Vmn2r32 signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that increases intracellular calcium levels, which could possibly activate GPCR signaling, including Vmn2r32. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Catalyzes ADP-ribosylation of Gi alpha proteins, inhibiting their activity and thus could possibly modify GPCR signaling, including Vmn2r32. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibitor of Ca2+/calmodulin-dependent protein kinase II, which could possibly affect GPCR signaling including Vmn2r32. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
Calcium channel blocker that can alter calcium influx, affecting GPCR signaling pathways which could possibly include Vmn2r32. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
Cholinergic agonist that activates phospholipase C through Gq protein-coupled receptors, potentially influencing GPCR signaling which could possibly activate Vmn2r32. | ||||||